GB201116364D0 - Screening methods and uses thereof - Google Patents

Screening methods and uses thereof

Info

Publication number
GB201116364D0
GB201116364D0 GBGB1116364.9A GB201116364A GB201116364D0 GB 201116364 D0 GB201116364 D0 GB 201116364D0 GB 201116364 A GB201116364 A GB 201116364A GB 201116364 D0 GB201116364 D0 GB 201116364D0
Authority
GB
United Kingdom
Prior art keywords
screening methods
methods
screening
ligands
differentially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1116364.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioinvent International AB
Original Assignee
Bioinvent International AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinvent International AB filed Critical Bioinvent International AB
Priority to GBGB1116364.9A priority Critical patent/GB201116364D0/en
Publication of GB201116364D0 publication Critical patent/GB201116364D0/en
Priority to AU2012311542A priority patent/AU2012311542B2/en
Priority to JP2014531238A priority patent/JP6370220B2/ja
Priority to CN201710970655.5A priority patent/CN107663238A/zh
Priority to DK12766050.4T priority patent/DK2758532T3/en
Priority to KR1020147010622A priority patent/KR102024125B1/ko
Priority to EP12766050.4A priority patent/EP2758532B1/en
Priority to PL12766050T priority patent/PL2758532T3/pl
Priority to PCT/EP2012/068576 priority patent/WO2013041643A1/en
Priority to IN1795DEN2014 priority patent/IN2014DN01795A/en
Priority to CN201280046053.6A priority patent/CN103827302A/zh
Priority to SI201231397T priority patent/SI2758532T1/sl
Priority to HUE12766050A priority patent/HUE040567T2/hu
Priority to CA2848932A priority patent/CA2848932C/en
Priority to RU2014115956A priority patent/RU2622089C2/ru
Priority to US14/346,432 priority patent/US10191049B2/en
Priority to PT12766050T priority patent/PT2758532T/pt
Priority to HK15100796.9A priority patent/HK1200486B/xx
Priority to ES12766050.4T priority patent/ES2690783T3/es
Priority to JP2018077210A priority patent/JP2018154627A/ja
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/6857Antibody fragments
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Oncology (AREA)
GBGB1116364.9A 2011-09-22 2011-09-22 Screening methods and uses thereof Ceased GB201116364D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB1116364.9A GB201116364D0 (en) 2011-09-22 2011-09-22 Screening methods and uses thereof
ES12766050.4T ES2690783T3 (es) 2011-09-22 2012-09-20 Métodos de cribado y usos de los mismos
PCT/EP2012/068576 WO2013041643A1 (en) 2011-09-22 2012-09-20 Screening methods and uses thereof
CN201280046053.6A CN103827302A (zh) 2011-09-22 2012-09-20 筛选方法及其应用
CN201710970655.5A CN107663238A (zh) 2011-09-22 2012-09-20 筛选方法及其应用
DK12766050.4T DK2758532T3 (en) 2011-09-22 2012-09-20 SCREENING PROCEDURES AND APPLICATIONS THEREOF
KR1020147010622A KR102024125B1 (ko) 2011-09-22 2012-09-20 스크리닝 방법 및 이의 용도
EP12766050.4A EP2758532B1 (en) 2011-09-22 2012-09-20 Screening methods and uses thereof
PL12766050T PL2758532T3 (pl) 2011-09-22 2012-09-20 Sposoby badania przesiewowego i ich zastosowania
AU2012311542A AU2012311542B2 (en) 2011-09-22 2012-09-20 Screening methods and uses thereof
IN1795DEN2014 IN2014DN01795A (https=) 2011-09-22 2012-09-20
JP2014531238A JP6370220B2 (ja) 2011-09-22 2012-09-20 スクリーニング方法およびその使用
SI201231397T SI2758532T1 (sl) 2011-09-22 2012-09-20 Presejalni postopki in njihove uporabe
HUE12766050A HUE040567T2 (hu) 2011-09-22 2012-09-20 Szkrínelõ eljárások és azok alkalmazásai
CA2848932A CA2848932C (en) 2011-09-22 2012-09-20 Screening methods and uses thereof
RU2014115956A RU2622089C2 (ru) 2011-09-22 2012-09-20 Способы скрининга и их применения
US14/346,432 US10191049B2 (en) 2011-09-22 2012-09-20 Screening methods and uses thereof
PT12766050T PT2758532T (pt) 2011-09-22 2012-09-20 Métodos de rastreio e utlizações dos mesmos
HK15100796.9A HK1200486B (en) 2011-09-22 2012-09-20 Screening methods and uses thereof
JP2018077210A JP2018154627A (ja) 2011-09-22 2018-04-13 スクリーニング方法およびその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1116364.9A GB201116364D0 (en) 2011-09-22 2011-09-22 Screening methods and uses thereof

Publications (1)

Publication Number Publication Date
GB201116364D0 true GB201116364D0 (en) 2011-11-02

Family

ID=44937671

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1116364.9A Ceased GB201116364D0 (en) 2011-09-22 2011-09-22 Screening methods and uses thereof

Country Status (17)

Country Link
US (1) US10191049B2 (https=)
EP (1) EP2758532B1 (https=)
JP (2) JP6370220B2 (https=)
KR (1) KR102024125B1 (https=)
CN (2) CN107663238A (https=)
AU (1) AU2012311542B2 (https=)
CA (1) CA2848932C (https=)
DK (1) DK2758532T3 (https=)
ES (1) ES2690783T3 (https=)
GB (1) GB201116364D0 (https=)
HU (1) HUE040567T2 (https=)
IN (1) IN2014DN01795A (https=)
PL (1) PL2758532T3 (https=)
PT (1) PT2758532T (https=)
RU (1) RU2622089C2 (https=)
SI (1) SI2758532T1 (https=)
WO (1) WO2013041643A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2392723B (en) 2002-09-04 2005-01-12 Bioinvent Int Ab Screening methods
WO2011140241A2 (en) 2010-05-04 2011-11-10 The General Hospital Corporation Methods and compositions for preserving tissues and organs
GB201116364D0 (en) 2011-09-22 2011-11-02 Bioinvent Int Ab Screening methods and uses thereof
JP6465407B2 (ja) * 2013-11-22 2019-02-06 株式会社Molcure 標的分子に結合するポリペプチドの決定方法及び決定システム
EP3698628A1 (en) 2014-08-07 2020-08-26 The General Hospital Corporation Stabilization of whole blood samples
CN109651506B (zh) * 2017-10-11 2021-12-07 上海交通大学 一种快速获得抗原特异性抗体的方法
CN119384696A (zh) * 2022-06-13 2025-01-28 生物发明国际公司 分离反配体的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366862A (en) 1990-02-14 1994-11-22 Receptor Laboratories, Inc. Method for generating and screening useful peptides
AU8081491A (en) 1990-06-01 1991-12-31 Cetus Corporation Compositions and methods for identifying biologically active molecules
AU1378495A (en) 1993-12-27 1995-07-17 Hamilton Civic Hospitals Research Development, Inc. Methods and compositions for inhibiting thrombogenesis
US6794128B2 (en) 1998-04-24 2004-09-21 The Regents Of The University Of California Methods of selecting internalizing antibodies
WO2000052054A2 (en) 1999-03-01 2000-09-08 Genentech, Inc. Antibodies for cancer therapy and diagnosis
US7135287B1 (en) 1999-10-02 2006-11-14 Biosite, Inc. Human antibodies
AU2002220236A1 (en) 2000-11-09 2002-05-21 Bionova Pharmaceutials, Inc. A method for identifying the proteome of cells using an antibody library microarray
GB2392723B (en) 2002-09-04 2005-01-12 Bioinvent Int Ab Screening methods
CN100575489C (zh) 2003-05-14 2009-12-30 多曼蒂斯有限公司 从多肽全能文库恢复可逆可解折叠多肽的方法
US20090005257A1 (en) 2003-05-14 2009-01-01 Jespers Laurent S Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire
GB0422431D0 (en) * 2004-10-08 2004-11-10 Affitech As Method
EP2254909A4 (en) 2007-12-21 2012-05-02 Ca Nat Research Council NON-AGGREGATING HUMANS VH DOMAINS
GB201116364D0 (en) 2011-09-22 2011-11-02 Bioinvent Int Ab Screening methods and uses thereof

Also Published As

Publication number Publication date
EP2758532A1 (en) 2014-07-30
KR102024125B1 (ko) 2019-09-23
RU2622089C2 (ru) 2017-06-09
JP2018154627A (ja) 2018-10-04
HK1200486A1 (en) 2015-08-07
KR20140080504A (ko) 2014-06-30
PT2758532T (pt) 2018-11-07
PL2758532T3 (pl) 2018-12-31
EP2758532B1 (en) 2018-07-11
ES2690783T3 (es) 2018-11-22
HUE040567T2 (hu) 2019-03-28
US20140227249A1 (en) 2014-08-14
CA2848932A1 (en) 2013-03-28
AU2012311542B2 (en) 2017-09-21
DK2758532T3 (en) 2018-10-22
WO2013041643A1 (en) 2013-03-28
US10191049B2 (en) 2019-01-29
AU2012311542A1 (en) 2014-03-20
JP2015501289A (ja) 2015-01-15
IN2014DN01795A (https=) 2015-05-15
CA2848932C (en) 2020-12-29
SI2758532T1 (sl) 2018-12-31
CN107663238A (zh) 2018-02-06
RU2014115956A (ru) 2015-10-27
CN103827302A (zh) 2014-05-28
JP6370220B2 (ja) 2018-08-08

Similar Documents

Publication Publication Date Title
MX2019008212A (es) Estructuras fibrosas que comprenden particulas y metodos para fabricarlas.
IN2015DN01300A (https=)
EP2880580A4 (en) ANALYSIS OF INFORMATION OF A VULNERABILITY VECTOR
GB201116364D0 (en) Screening methods and uses thereof
EP2697648A4 (en) SYSTEM FOR DETECTING A SAMPLE ON A BIOPUCE
IN2015DN00636A (https=)
EP2806874A4 (en) Specific chemical substances, compositions and methods
GB201420112D0 (en) Business process analytics
EP2880050A4 (en) NOVEL ENZYMES, ENZYME COMPONENTS AND USES THEREOF
SG11201405481SA (en) Biocontrol
EP2826862A4 (en) SYNTHESIS METHOD OF GENES, DNA CHIP AND KIT
PH12022550138A1 (en) Proteins specific for baff and b7rp1 and uses thereof
BRPI1105770A2 (pt) processamento de gás de hidrocarbonetos.
EP2753174A4 (en) PARTICULAR CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
WO2013049398A3 (en) Protein-protein interaction as biomarkers
PL2681532T3 (pl) Wyznaczanie DNA i/lub RNA na podstawie danych ze spektrofotometru UV-VIS
GB201200173D0 (en) Encrypted data processing
IN2014DN07103A (https=)
GB2510784B (en) Data sharing using difference-on-write
BRPI1105771A2 (pt) processamento de gás de hidrocarboneto.
GB201216482D0 (en) Novel lipases,polynucleotides encoding them and their uses
MX2013002111A (es) Metodos y composiciones para el tratamiento de metastasis del cancer.
WO2014047453A3 (en) Screening polynucleotide libraries for variants that encode functional proteins
IL236814A0 (en) The assembly of DNA segments in high yield
GB201209420D0 (en) Prognostic gene

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)